Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...

“The projects awarded pilot studies grants for 2026 address important clinical and translational science questions,” says CTSI Director Sanjay Sethi, MD, SUNY Distinguished Professor of medicine and ...

Some of the best AI interior design tools you can use to organize your home without paying any fees include Homebyme, Spacely ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

North America held a dominant market position, capturing more than a 34.26% share, holding USD 5.56 billion in revenue.

We’re living through something extraordinary. Artificial intelligence isn’t just a futuristic concept anymore; it’s embedded ...

Six CFR fellows examine the challenges that lie ahead, reviewing how governance, adoption, and geopolitical competition will ...

Artificial intelligence is no longer a distant future technology; it is already changing how people work across the world. This first part of a two‑part series explains three key AI trends for 2026 ...

Lantern Pharma Inc. (NASDAQ: LTRN), a pioneer in AI-driven precision oncology and computational therapeutic development, today announced the establishment of an A.I. Center of Excellence and Advanced ...

Companies investing in unified, managed and rich data layers will drive innovation in the coming decade. Through these ...

More than half of healthcare organizations in the United States now operate with formal digital transformation strategies, ...

Energy-efficient HVAC systems, solar power, smart lighting, and water-saving infrastructure Information technology ...